Danaher (DHR)

• Market cap: $140B
• 1 day: 1.21%
• 5 days: 0.14%
• 1 month: -6.57%
• 3 months: 0.43%
• 6 months: -8.23%
• Year to date: -15.03%
• 1 year: -28.18%
• 5 years: 6.76%
• 10 years: 237.02%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

Employees: 63,000

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

65% more call options, than puts

Call options by funds: $1.04B | Put options by funds: $630M

1.28% more ownership

Funds ownership: 78.89% [Q1] → 80.17% (+1.28%) [Q2]

2% less capital invested

Capital invested by funds: $116B [Q1] → $113B (-$2.39B) [Q2]

4% less repeat investments, than reductions

Existing positions increased: 842 | Existing positions reduced: 874

2% less funds holding

Funds holding: 2,197 [Q1] → 2,144 (-53) [Q2]

8% less funds holding in top 10

Funds holding in top 10: 59 [Q1] → 54 (-5) [Q2]

10% less first-time investments, than exits

New positions opened: 148 | Existing positions closed: 165

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $205
• Avg. target: $234
• High target: $275

7 analyst ratings

• positive: 6 86%
• neutral: 1 14%
• negative: 0 0%

UBS Dan Leonard	$225	Buy Maintained	23 Jul 2025
Wells Fargo Brandon Couillard	$205	Equal-Weight Maintained	23 Jul 2025
Guggenheim Subbu Nambi	$250	Buy Reiterated	23 Jul 2025
Baird Catherine Schulte	$229	Outperform Maintained	23 Jul 2025
Scotiabank Sung Ji Nam	$275	Sector Outperform Upgraded	11 Jul 2025